1468eTiP A safety, feasibility, and efficacy study of gemcitabine plus docetaxel plus toripalimab (GDT) induction as part of a curative sequential chemoradiation for patients with locoregional EBV-associated nasopharyngeal carcinoma (NPC)
Year: 2025
Type: article
Source: Annals of Oncology
Institutions: Stanford Medicine, Stanford University, Stanford Cancer Institute
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415942128